FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and ...

The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with ...

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the ...

What makes glaucoma especially dangerous is its lack of early symptoms. A doctor explains why screening matters.

Lehi, Utah - January 14, 2026 - PRESSADVANTAGE - Waite Vision has announced the publication of a new article titled Dr.

SIOUX FALLS, SD - January 23, 2026 - PRESSADVANTAGE - Vance Thompson Vision is drawing attention to its advanced ...

Check out our weekly list of new fundraisers from Lend A Hand Up, a nonprofit crowdfunding site supporting families in Cass, Steele, Traill, Grand Forks, Clay, Otter Tail, Becker, Norman, Polk, Red ...

LONDON and NEW YORK, Jan. 23, 2026), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseas ...

Find Tips And Tricks Latest News, Videos & Pictures on Tips And Tricks and see latest updates, news, information from ...

Patients with retinal diseases who were treated with anti-VEGF therapies through manufacturer patient assistance programs ...